Ruthenium (II) compounds for use in the therapy of cancer
US6936634B2 · kind B2 · utility
1Cited by
4References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2001 |
| Grant date | Aug 30, 2005 |
| Priority date | — |
| Expiry date | Jun 26, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F15/0046
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which may be used in the treatment and/or prevention of cancer have the formula (I): wherein R1 and R2 together with the ring to which they are bound represent a saturated or unsaturated carbocyclic or heterocyclic group
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.